BioMed Research International

Volume 2014 (2014), Article ID 839019, 8 pages

http://dx.doi.org/10.1155/2014/839019

Research Article

High-Level Antimicrobial Efficacy of Representative Mediterranean Natural Plant Extracts against Oral Microorganisms

Lamprini Karygianni,¹ Manuel Cecere,¹ Alexios Leandros Skaltsounis,² Aikaterini Argyropoulou,² Elmar Hellwig,¹ Nektarios Aligiannis,² Annette Wittmer,³ and Ali Al-Ahmad¹

¹Department of Operative Dentistry and Periodontology, Center for Dental Medicine, University of Freiburg, Hugstetter Straße 55, 79106 Freiburg, Germany

²Department of Pharmacognosy and Natural Product Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, 15771 Athens, Greece

³Department of Hygiene and Microbiology, Albert-Ludwigs University, 79104 Freiburg, Germany

Received 24 April 2014; Revised 6 June 2014; Accepted 7 June 2014; Published 26 June 2014

Academic Editor: Nikos Chorianopoulos

Copyright © 2014 Lamprini Karygianni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Nature is an unexplored reservoir of novel phytopharmaceuticals. Since biofilm-related oral diseases often correlate with antibiotic resistance, plant-derived antimicrobial agents could enhance existing treatment options. Therefore, the rationale of the present report was to examine the antimicrobial impact of Mediterranean natural extracts on oral microorganisms. Five different extracts from Olea europaea, mastic gum, and Inula viscosa were tested against ten bacteria and one Candida albicans strain. The extraction protocols were conducted according to established experimental procedures. Two antimicrobial assays—the minimum inhibitory concentration (MIC) assay and the minimum bactericidal concentration (MBC) assay—were applied. The screened extracts were found to be active against each of the tested microorganisms. O. europaea presented MIC and MBC ranges of 0.07–10.00 mg mL⁻¹ and 0.60–10.00 mg mL⁻¹, respectively. The mean MBC values for mastic gum and I. viscosa were 0.07–10.00 mg mL⁻¹ and 0.15–10.00 mg mL⁻¹, respectively. Extracts were less effective against C. albicans and exerted bactericidal effects at a concentration range of 0.07–5.00 mg mL⁻¹ on strict anaerobic bacteria (Porphyromonas gingivalis, Prevotella intermedia, Fusobacterium nucleatum, and Parvimonas micra). Ethyl acetate I. viscosa extract and total mastic extract showed considerable antimicrobial activity against oral microorganisms and could therefore be considered as alternative natural anti-infectious agents.

1. Introduction

The Hippocratic statement “Nature, without instruction or knowledge, does what is necessary” wisely acknowledges the healing contribution of the vegetable kingdom to the treatment of various diseases. The potential of a small fraction of natural plant extracts to cure serious infections of the human body has been well established to date [1–4]. In particular, various Mediterranean natural herb products have been screened profitably for their antioxidant and antimicrobial effects [5–8]. Origanum dictamnus, Olea europaea, Chios mastic gum, Inula viscosa, Petroselinum crispum, and Sideritis spp. are some of the most well-known examples [7, 9, 10]. Nevertheless, the biological behavior of over 300.000 existing plant species needs to be further studied [11].

The remarkable immunostimulatory activity of several plant species is also responsible for the low occurrence of infectious processes in their wild counterparts. The most known broad-spectrum defense mechanisms of plant-originated antimicrobial agents are related to the presence of “phytoalexins.” The latter are small-molecule antibiotics (molecular weight: MW < 500) and according to their classification include polyphenols, flavonoids, terpenoids, and glycosteroids [12]. In order to conquer the pathogenic attackers, the aforementioned mild antimicrobials usually act synergistically. Moreover, the production of callose, a sugar polymer with (1–3)-β-D-glucan subunits, at the microbial invasion sites on the plant cell wall constitutes a typical pathogen-specific response of vegetable organisms [13]. The secretion of resistance () proteins triggered by avirulence (Avr) genes in the presence of attacking microorganisms is also another microbe-specific defense of plants [14].

Bacteria, viruses, and fungi are the cause of numerous infectious diseases. They are official residents of the human body and are capable of forming biofilms, dynamic microbial networks, on human substrata [15]. In the oral cavity in particular, more than 700 microbial species have been recovered, either being in a planktonic form or being embedded in a polysaccharide-affluent extracellular layer [16]. Despite the unfriendly conditions on tooth surfaces and gingival tissues, oral microorganisms are skilled at surviving through complicated physicochemical intercommunication patterns with the oral substrata [17]. The harmful microbial impact on these surfaces results in the genesis of caries, gingivitis, or periodontitis.

Recent years have seen a focus in oral microbiology research on the elucidation and elimination of biofilm-related dental diseases [18, 19]. Microbial biofilm communities have been found to be up to 1000 times more resistant to antibiotics against their equivalent planktonic cultures, while multidrug-resistant oral microorganisms have been identified [19]. The presence of vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) underlines the limits of antibiotics in facing this primary health hazard with regard to the oral cavity [20]. Furthermore, an endocarditis-associated Enterococcus faecalis virulence gene named efaA has been recovered from therapy-resistant strains in root canals [21].

The need to discover new efficient treatment strategies against oral microbial species has raised interest in natural vegetable sources. Novel antimicrobial agents of plant origin aim to reintroduce traditional treatment paradigms to modern medicine. Indeed, plants exhibit a remarkable pharmaceutical range due to their secondary metabolism-mediated chemical responses to various microorganisms and the synergistic paradigms they develop. The latter prevent microbes from resisting antibiotic monotherapy and, therefore, becoming untreatable.

The aim of the present report was to examine the antimicrobial activity of natural plant and fruit extracts of Mediterranean origin against various microbial species. More specifically, five different extracts from olive leaves, table olives, mastic gum, and Inula viscosa (Syn. Dittrichia viscosa) were screened against a panel of nine relevant pathogenic microorganisms, which constitute typical residents of the oral microflora, including one strain of Candida albicans. Additionally, Staphylococcus aureus and Escherichia coli, normally a part of skin and intestinal flora, served as reference bacterial strains. The null hypothesis of this report was that the aforementioned extracts have no antimicrobial impact on the tested microorganisms. For this purpose, two antimicrobial assays—the minimum inhibitory concentration (MIC) assay and the minimum bactericidal concentration (MBC) assay—were utilized.

2. Materials and Methods

2.1. Extraction Process

2.1.1. Olive Leaves

Olea europaea leaves were dried in a well-ventilated shady place and subsequently stored in a dark room. Before their extraction, the leaves were ground using an Allen West type SCIS grinder with a sieve of 3 mm. The leaves (3.5 Kg) were extracted by mechanical stirring for 12 h with acetone (2 × 2.5 L). The extract was evaporated completely and washed with a mixture of CH₂Cl₂/MeOH 98 : 2 (3 L). The insoluble material was separated and dried under reduced pressure, producing a yellow powder (360 g) containing 60% oleuropein [22].

2.1.2. Table Olive Processing Wastewater

Olive fruits were cured for a period of 4 months, using an aqueous solution of 8% NaCl (w/v). The water extract (400 mL) was applied to Amberlite XAD-4 resin and the column eluted with 96% ethanol. After desorption, ethanol was evaporated by drying at 40°C and the phenolic fraction (1.34 g) was recovered [22, 23].

2.1.3. Conventional Extraction of Mastic Gum

A quantity of mastic gum (500 g) was diluted in ethyl acetate (500 mL). 1,500 mL of methanol was then added. After a period of 2 days, a layer of poly-β-myrcene (150 g) was decanted. Filtration was applied in order to obtain a clear supernatant solution and the solvent mixture was evaporated in a rotary evaporator at 45°C with an 80 kPa vacuum (extraction A). The resulting semisolid residue was dried in a desiccator at 70°C and 1,000-mbar vacuum and resulted in a white powder (350 g) [24].

2.1.4. Inula viscosa

Inula viscosa (Asteraceae) was extracted with pressurized liquid extraction. For that purpose, a Dionex accelerated solvent extraction (ASE) 300 System (Dionex, Sunnyvale, CA) with 100 mL stainless steel vessels was used. Specifically, 20 g of ground . viscosa aerial parts was placed into tubular extraction cells. These were then placed into the carousel and the samples were extracted under the specified conditions: temperature: 70°C, pressure: 120 bar (preset by the instrument), preheat time: 1 min, heat time: 5 min, 2 extraction cycles of 5 min static time each, flush volume: 100%, and purge: 120 sec. Separate preparations of ethyl acetate extracts and methanol extracts were made. Analytical grade ethyl acetate and methanol were used and were evaporated to dryness under reduced pressure using a rotary evaporator (Buchi Rotavapor R-200) at 40°C. The obtained yields were 2.08 gr for the ethyl acetate extraction and 3.51 gr for the methanol.

2.2. Chemical Analysis of Extracts

The qualitative and quantitative determination of the tested extracts (olive leaves, table olive processing wastewater, and Inula viscosa) was performed in a HPLC-DAD system: Thermo Finnigan HPLC system (Thermo Finnigan, San Jose, CA) coupled with a Spectral System UV6000LP PDA detector. A two-solvent gradient method was used: (A) H₂O and (B) acetonitrile. The flow rate was set at 1 mL/min and the following elution program was applied: 0–60 min linear gradient from 0% A to 50% B; 60–65 min linear gradient to 100% B; 65–70 min 100% B isocratic; 70–75 min linear gradient to 0% B; 75–85 min 0% B isocratic. The analysis was performed at 25°C and the injection volume was 20 μL. The detection was done at 280 nm and the column used was Supelco Analytical Discovery HS C18 (25 cm 4.6 mm i.d., 5.0 μm). Standard solutions of oleuropein and hydroxytyrosol were prepared and run under the same conditions in the case of olive leaves and table olive processing wastewater extracts [22, 23].

Concerning mastic gum the tested extract was divided into two fractions, an acidic and a neutral one. The acidic fraction after several chromatographic separations afforded the major triterpenic acids: oleanonic acid, moronic acid, 24Z-masticadienonic acid, 24Z-isomasticadienonic acid, 24Z-masticadienolic acid, and 24Z-isomasticadienolic acid. The neutral fraction afforded five neutral triterpenic compounds: tirucallol, dammaradienone, 28-norolean-12-en-3-one, oleanonic aldehyde, and oleanolic aldehyde. All the above constituents were identified by NMR (1H, 13C, COSY, HMQC, and NOESY) and MS and by comparison with data in the literature. Nuclear magnetic resonance (NMR) spectra were recorded on Bruker DRX 400 and Bruker AC 200 (50.3 MHz for 13C NMR) instruments at 295 K. Gas chromatography mass spectroscopy (MS) analysis was performed on a Finnigan GCQ Plus mass spectrometer [22].

2.3. Bacterial and Fungal Strains

A total of ten bacterial strains from eight different species and one Candida albicans strain were investigated. Eight of the tested bacterial strains and C. albicans occur in the oral flora, whereas Staphylococcus aureus and Escherichia coli are mainly recovered from the skin and intestinal flora, respectively. The latter two were used as reference microorganisms to specifically compare the oral inhibitory effect of natural extracts to their general antimicrobial activity. In particular, Streptococcus mutans DSM 20523, Streptococcus sobrinus DSM 20381, Streptococcus oralis ATCC 35037, Enterococcus faecalis ATCC 29212, and S. aureus ATCC 25923 are facultative anaerobic Gram-positive species, whereas E. coli ATCC 25922 is also facultative anaerobic but has a Gram-negative cell wall. Porphyromonas gingivalis W381, Prevotella intermedia ATCC 25611, Fusobacterium nucleatum ATCC 25586, and Parvimonas micra ATCC 23195 are obligate anaerobes. All bacterial and fungal strains were kindly supplied by the Division of Infectious Diseases and the Institute of Medical Microbiology and Hygiene of the Albert-Ludwigs University, Freiburg. The microorganisms were deposited at −80°C in basic growth medium containing 15% (v/v) glycerol until their use.

2.4. Determination of the Minimum Inhibitory Concentration (MIC)

First, an overnight culture of each bacterial and fungal strain was prepared according to the CLSI guidelines [25, 26]. Each dilution was plated on Columbia blood agar (CBA) plates or yeast-cysteine blood agar (HCB) plates. Facultative anaerobic bacteria and C. albicans were incubated on CBA agar plates at 37°C and 5%–10% CO₂ atmosphere for 24 h. Anaerobic bacteria were placed on HCB agar plates at 37°C for 48 h (anaerobic chamber, Genbox BioMérieux SA, Marcy/Etoile, France). For the microdilution assay, all facultative anaerobic strains were inoculated in Mueller-Hinton broth (MHB), anaerobic bacteria in Wilkins-Chalgren broth (WCB), and C. albicans in Sabouraud dextrose broth (SDB), each to be tested at 10⁶ colony forming units (CFU) mL⁻¹. Afterwards, appropriate volumes of the MHB/WCB/SDB microbial cultures were transferred into a 96-well microtiter-plate using a multichannel pipette. The prepared natural extracts were then dissolved in dimethyl sulfoxide (DMSO, Sigma, Steinheim, Germany) and diluted in aqua destillata. All extract solutions in DMSO were screened in a concentration series ranging from 10 mg mL⁻¹ to 0.02 mg mL⁻¹ at dilution levels starting from 2-fold to 512-fold. The experiments were performed in duplicate. A 0.5/1 A McFarland standard suspension was prepared in normal saline for bacteria and fungi, respectively. Each well of the 96-well microtiter-plate had a total volume of 200 μL. In order to exclude potential antimicrobial effects of the DMSO residuals, a dilution series of DMSO was examined in parallel. Wells containing solely MHB/WCB/SDB or 0.2% chlorhexidine (CHX) served as positive and negative controls for bacterial growth, respectively. The possibility of contamination was minimized by using sterile MHB/WCB/SDB. Thereafter, facultative anaerobic bacteria and C. albicans were incubated at 37°C and 5%–10% CO₂ atmosphere for 24 h, while anaerobic bacteria were kept at 37°C for 48 h (anaerobic chamber, Genbox BioMérieux SA, Marcy/Etoile, France). All assays for each bacterial and fungal strain were performed at least in duplicate. The highest minimum inhibitory concentration (MIC) values were taken into consideration in case the MIC values of a specific strain were not identical. MIC was defined as the lowest concentration of each natural extract at which visible inhibition of bacterial growth was induced and was thus expressed by the percentage of bacterial growth at that particular concentration. The inhibitory impact of DMSO was taken into consideration if bacterial growth was observed in the cotested DMSO dilution series.

2.5. Determination of the Minimum Bactericidal Concentration (MBC)

The minimum bactericidal concentration (MBC) was also assessed according to the CLSI guidelines [25, 26]. After completion of the MIC assay, the aforementioned 96-well microtiter-plates were further incubated for MBC testing. In brief, 10 μL from each well containing the tested natural extract concentration series was plated on Columbia blood agar (CBA) or yeast-cysteine blood agar (HCB) plates. In particular, the facultative anaerobic bacteria and C. albicans were incubated on CBA plates at 37°C and 5%–10% CO₂ atmosphere for 2 days. Strictly anaerobic bacteria were cultivated on HCB plates at 37°C for 5 days (anaerobic chamber, Genbox BioMérieux SA, Marcy/Etoile, France). The colony forming units (CFU) were determined visually. The MBC was defined as the concentration at which a three-log decrease in bacterial growth (= 99.9%) was detected compared to the positive control.

3. Results

3.1. Olea europaea

Two extracts produced from olive processing byproducts were tested. Extraction of olive leaves with acetone afforded a polar fraction which was defatted with a mixture of CH₂Cl₂/MeOH 98 : 2. The obtained extract contained 60% oleuropein. The extract coming from table olive processing wastewater contained as its main compound, the degradation product of oleuropein, hydroxytyrosol, in a percentage around 15%.

The mean MIC and MBC values for each of the O. europaea extracts as well as the tested bacterial/fungal strains are presented in Table 1.

Table 1: Antimicrobial activity in mg mL⁻¹ of olive leaf and table olives extracts (O. europaea).

Sample
Olive leaf extract
Table olives extract
DMSO (%)

c/mg mL⁻¹
MIC*
MBC**
MIC
MBC
MIC
MBC

Streptococcus mutans DSM 20523
1.25
NA
1.25
5.00
5.00
40.00

Streptococcus sobrinus DSM 20381
2.50
NA
2.50
5.00
20.00
20.00

Streptococcus oralis ATCC 35037
0.07
NA
1.25
2.50
10.00
20.00

Enterococcus faecalis ATCC 29212
0.60
NA
5.00
NA
20.00
80.00

Candida albicans DSM 1386
NA
NA
NA
NA
10.00
10.00

Escherichia coli ATCC 25922
NA
NA
5.00
NA
20.00
40.00

Staphylococcus aureus ATCC 25923
2.50
5.00
2.50
2.50
20.00
40.00

Porphyromonas gingivalis W381
0.30
0.60
0.15
1.25
5.00
20.00

Prevotella intermedia ATCC 25611
2.50
5.00
0.30
0.60
2.50
5.00

Fusobacterium nucleatum ATCC 25586
0.60
1.25
0.60
2.50
10.00
10.00

Parvimonas micra ATCC 23195
0.30
1.25
0.15
0.60
10.00
20.00

NA: no activity observed; MIC or MBC was measured at 10.00 mg mL⁻¹.

MIC: extract concentration at which the optical density (OD) measurement revealed minimal bacterial growth.

MBC: extract concentration at which a three-log reduction (99.9%) of the bacterial growth was induced.

In general, table olive extract was more active than olive leaf extract. It was effective against almost all of the tested microorganisms, with a mean concentration range of 0.15 mg mL⁻¹ (Porphyromonas gingivalis, Parvimonas micra) to 10.00 mg mL⁻¹ (Candida albicans). For the facultative anaerobic bacteria MIC values varied between 1.25 mg mL⁻¹ (Streptococcus mutans, Streptococcus oralis) and 5.00 mg mL⁻¹ (Enterococcus faecalis). The MBC values of the table olive extract ranged from 0.60 to 10.00 mg mL⁻¹. Obligate anaerobes (Prevotella intermedia, P. micra) were more easily eradicated (0.60 mg mL⁻¹) when compared to E. faecalis and C. albicans (10.00 mg mL⁻¹).

Olive leaf extracts showed a milder inhibitory effect against oral pathogens. The MIC values of the eradicated microbial strains were between 0.07 mg mL⁻¹ (S. oralis) and 10.00 mg mL⁻¹ (C. albicans, Escherichia coli). The MBC values demonstrated the persistence of facultative anaerobes in the presence of O. europaea leaf extracts (10.00 mg mL⁻¹). However, P. gingivalis was inhibited by 0.60 mg mL⁻¹ of the extract, while 1.25 mg mL⁻¹ killed 99.9% of Fusobacterium nucleatum and P. micra.

3.2. Mastic Gum

Table 2 summarizes the MIC and MBC values of the tested mastic gum extract for all screened microbial strains. A total mastic extract without polymer was prepared after removal of the contained insoluble polymer. The extensive characterization of the extract by NMR and MS revealed that it contained triterpenic acids, triterpenic alcohols, and aldehydes.

Table 2: Antimicrobial activity in mg mL⁻¹ of four mastic gum extracts.

Mastic gum

Sample
Total mastic extract
DMSO (%)

c/mg mL⁻¹
MIC*
MBC**
MIC
MBC

Streptococcus mutans DSM 20523
NA
NA
5.00
40.00

Streptococcus sobrinus DSM 20381
NA
NA
10.00
20.00

Streptococcus oralis ATCC 35037
2.50
5.00
10.00
20.00

Enterococcus faecalis ATCC 29212
NA
NA
10.00
80.00

Candida albicans DSM 1386
NA
NA
10.00
10.00

Escherichia coli ATCC 25922
NA
NA
10.00
10.00

Staphylococcus aureus ATCC 25923
2.50
5.00
20.00
80.00

Porphyromonas gingivalis W381
0.02
0.07
10.00
20.00

Prevotella intermedia ATCC 25611
0.07
0.30
2.50
5.00

Fusobacterium nucleatum ATCC 25586
2.50
2.50
10.00
20.00

Parvimonas micra ATCC 23195
0.60
0.60
2.50
10.00

NA: no activity observed; MIC or MBC was measured at 10.00 mg mL⁻¹.

MIC: extract concentration at which a three-log reduction (99.9%) of the bacterial growth was induced.

MBC: extract concentration at which a three-log reduction (99.99%) of the bacterial growth was induced.

Total mastic extract was effective against all of the microorganisms with MIC values ranging from 0.02 mg mL⁻¹ (P. gingivalis) to 10 mg mL⁻¹. The mean MBC values were between 0.07 mg mL⁻¹ (P. gingivalis, P. micra) and 10.00 mg mL⁻¹ (S. mutans, S. sobrinus, E. faecalis, C. albicans, and E. coli). Extract concentrations between 0.07 and 2.50 mg mL⁻¹ exerted bactericidal effect mainly on strict anaerobic, Gram-negative bacteria (P. gingivalis, P. intermedia, and F. nucleatum).

3.3. Inula viscosa

Table 3 summarizes the range of MIC and MBC values of the two tested I. viscosa extracts against the selected oral bacterial/fungal strains. Aerial parts of I. viscosa were extracted with two solvents of different polarity, following a separate extraction. Ethyl acetate extract afforded medium polarity compounds, mainly flavonoids such as 3-O-acetylpadmatin, 7-O-methylaromadendrin, hispidulin, apigenin, luteolin, sesquiterpenic compounds, and triterpenoids. While the methanol extract contained some common compounds with the ethyl acetate extract, phenolic acids and flavonoids were also detected.

Table 3: Antimicrobial activity in mg mL⁻¹ of I. viscosa extracts.

Sample
Ethyl acetate extract
Methanol extract
DMSO (%)

c/mg mL⁻¹
MIC*
MBC**
MIC
MBC
MIC
MBC

Streptococcus mutans DSM 20523
0.15
1.25
1.25
5.00
5.00
40.00

Streptococcus sobrinus DSM 20381
2.50
2.50
2.50
5.00
20.00
20.00

Streptococcus oralis ATCC 35037
0.30
0.30
0.60
0.60
10.00
20.00

Enterococcus faecalis ATCC 29212
2.50
5.00
5.00
5.00
20.00
80.00

Candida albicans DSM 1386
1.25
2.50
5.00
5.00
10.00
10.00

Escherichia coli ATCC 25922
2.50
5.00
NA
NA
20.00
40.00

Staphylococcus aureus ATCC 25923
0.60
1.25
1.25
2.50
20.00
40.00

Porphyromonas gingivalis W381
0.07
0.15
0.15
0.30
5.00
20.00

Prevotella intermedia ATCC 25611
0.15
0.30
0.30
0.60
2.50
5.00

Fusobacterium nucleatum ATCC 25586
0.30
0.60
0.60
1.25
10.00
10.00

Parvimonas micra ATCC 23195
0.15
0.60
0.60
1.25
10.00
20.00

NA: no activity observed; MIC or MBC was measured at 10.00 mg mL⁻¹.

MIC: extract concentration at which the optical density (OD) measurement revealed minimal bacterial growth.

MBC: extract concentration at which a three-log reduction (99.9%) of the bacterial growth was induced.

Among the two I. viscosa extracts, ethyl acetate extract presented a more robust antimicrobial effect against the screened microorganisms compared to the methanol extract. Under its influence, a mean inhibitory concentration range of 0.07 mg mL⁻¹ (P. gingivalis) to 2.50 mg mL⁻¹ (S. sobrinus, E. faecalis, and E. coli) was observed. The MBC values of the ethyl acetate extract varied from 0.15 to 5.00 mg mL⁻¹. Obligate anaerobes such as P. gingivalis (0.15 mg mL⁻¹) were efficiently eliminated by reduced extract concentrations as compared to the more persistent E. faecalis and E. coli strains (5.00 mg mL⁻¹).

The I. viscosa methanol extract also had a considerable inhibitory impact on oral bacteria and fungi. The MIC values of the eradicated microorganisms ranged between 0.15 mg mL⁻¹ (P. gingivalis) and 10.00 mg mL⁻¹ (E. coli). The MBC values ranged from 0.30 to 10.00 mg mL⁻¹. Hence, P. gingivalis was eliminated by 0.30 mg mL⁻¹ of the extract, while 0.60 mg mL⁻¹ induced a three-log reduction in bacterial growth for P. intermedia and S. oralis.

4. Discussion

Taking the antibiotic resistance of oral biofilms into consideration, the present study aimed to introduce novel plant-derived antimicrobial agents in the treatment of therapy-persistent dental diseases. Hence, the antimicrobial impact of five different Mediterranean natural plant and fruit extracts was investigated on representative oral bacterial strains and C. albicans. To the best of our knowledge, this is the first report on the antimicrobial efficacy of Olea europaea, mastic gum, and Inula viscosa against microorganisms which belong to the commensal flora of the oral cavity.

In this study, the tested O. europaea extracts were found to be especially effective against Gram-negative, anaerobic periodontal pathogens such as Porphyromonas gingivalis, Prevotella intermedia, and Fusobacterium nucleatum. Indeed, there are several reports on the excellent antibacterial activity of O. europaea extracts and pure compounds using diverse microbial species [7, 27–29]. Sudjana et al. substantiated the narrow-spectrum antibacterial action of commercial olive leaf extract against Campylobacter jejuni, Helicobacter pylori, and Staphylococcus aureus, as well as against methicillin-resistant S. aureus (MRSA) [30]. This highlights the regulatory interference of O. europaea extracts with gastric Gram-negative microorganisms such as C. jejuni and H. pylori. In another report olive leaf extracts succeeded in eliminating the Gram-negative Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae [31]. However, Gram-negative microorganisms are often resistant to conventional antimicrobial drugs because of their expression of active efflux pumps [32]. Their tenacious nature is also assisted by the release of degrading enzymes and molecular metamorphosis of antibiotic targets [33]. Moreover, the overdelicate structure of Gram-negative bacteria, which involves structural discrepancies between the cell wall and exterior membrane, influences their susceptibility to various antimicrobial agents [34].

Furthermore, table olive extract presented milder antistaphylococcal activity, suggesting an additional impact on Gram-positive bacteria. A previous report described the antimicrobial efficacy of O. europaea leaves towards the Gram-positive Bacillus cereus [27]. The exact infiltration and destruction mechanism of the Gram-positive cell wall by O. europaea extracts probably implies the presence of antiquorum sensing (QS) compounds [35]. Since the pathogenicity of Gram-positive microorganisms such as S. aureus is based on small peptides named “quormones” triggered by the agr operon or analogous QS communication patterns, O. europaea could assumingly interfere with their action [36]. Contrary to the results of an earlier study, Candida albicans was not found susceptible to table olive extract [27]. The conflicting outcomes can be attributed to the differing extraction methods which were used, including boiling. However, which of the numerous phenolic or other compounds was responsible for this favorable effect remains unknown. In the present study, the two main compounds of the extracts were oleuropein in olive leaves and hydroxytyrosol in table olive processing wastewater. A lot of studies claim the strong antimicrobial activity of the two compounds [22, 37].

Mastic gum constitutes a stem-derived resinous exudate of the Mediterranean tree Pistacia lentiscus var. chia. P. gingivalis, P. intermedia, F. nucleatum, and P. micra demonstrated high susceptibility toall of the mastic gum extracts studied. The numerous reports on the favorable antimicrobial properties of mastic gum also underline its effectiveness against various pathogens [6, 24, 38–40]. More specifically, a commercial product containing mastic in the liquid form (2%) showed a narrow antibacterial spectrum against Gram-negative P. gingivalis and Prevotella melaninogenica [40]. Gram-positive bacteria (Streptococcus mutans, S. aureus) as well as fungi (C. albicans) were not influenced. Takahashi et al. confirmed a decrease in the total number of bacterial salivary colonies after 4 hours of chewing mastic gum [41]. Since side effects such as tooth discoloration and enhanced cell toxicity accompany the application of conventional oral antibacterial chemicals such as chlorhexidine (CHX), the introduction of mastic-derived mouth rinses could promote antiplaque activity with minimal drawbacks.

In general, mastic gum is composed of various volatile ingredients, the most important of which are α-pinene, β-myrcene, β-caryophyllene, β-pinene, and limonene [6]. The herein tested extract, though, contained mostly triterpenic acids, which could be the active principles. It was previously found that total mastic extract without polymer containing mostly major triterpenic acids can efficiently eliminate other persistent microorganisms such as H. pylori. Reduced activity was observed for the triterpenic alcohols and aldehydes [24]. The additionally contained triterpenic alcohols and aldehydes have not showed a respective antimicrobial action. Koutsoudaki et al. detected moderate to high susceptibility of B. subtilis and S. aureus to β-myrcene, while E. coli exhibited no sensitivity to the substance [39]. Furthermore, β-pinene proved to be ineffective against E. coli and S. aureus, whereas B. subtilis showed only a mild response. These varying outcomes suggest that a synergistic activity of the different components of mastic gum extracts may be responsible for its antimicrobial action. Thus, the results of the present study indicate that the interdependent antimicrobial activity of the particular mastic ingredients focuses on eradicating therapy-resistant Gram-negative oral microorganisms.

In this study, I. viscosa was highly effective against not only Gram-negative anaerobic pathogens, but also streptococci (S. mutans, S. oralis). Although its advantageous effects in the oral cavity were demonstrated here for the first time, there are many reports appraising its general antibacterial, antifungal, and antiviral properties [42–45]. The difference between the activities of the two extracts could be attributed to the different chemical profile. Generally the two extracts contain a lot of common metabolites; however, the most polar ones are found at the methanol extract. In a previous report, methanol extracts of the plant demonstrated effective antimicrobial behavior against Gram-positive bacteria such as S. aureus, and E. faecalis, C. albicans, and Candida tropicalis were also found to be sensitive to I. viscosa, whereas Gram-negative bacteria were less susceptible [45]. The antimicrobial impact of I. viscosa was also observed on Bacillus cereus and Salmonella typhimurium. In addition, it was revealed that a compound of the plant named 3,3′-di-O-methylquercetin can deteriorate the cytoplasmic membranes after penetrating various bacterial cell walls [44]. Moreover, Wang et al. reported that I. viscosa presented fungicidal properties against pathogens of the families Oomycetes, Ascomycetes, and Basidiomycetes [46]. This is in agreement with the findings of this study, in which I. viscosa exerted bactericidal effects at a concentration range of 2.50–5.00 mg mL⁻¹ towards C. albicans.

Medicinal plants have proven to be a bountiful reservoir of numerous biologically active components with advanced antibacterial properties. It is well known that synthetic chemicals, which are commonly used in dental products such as toothpastes and oral mouthwashes, can induce tooth discoloration, cell toxicity, regurgitation, or diarrhea [47, 48]. Thus, plant extracts are considered to be potent alternative compounds for the new generation of oral pharmaceuticals. In fact, novel plant-derived constituents of dental chemotherapeutics (mouth rinses, irrigation solutions, and intracanal medicaments) are crucial future sources of the dental industry specializing in plaque-control strategies, since they allow for efficient treatment regarding antibiotic-resistant pathogens, immunocompromised individuals, and financially weak developing countries.

5. Conclusion

In conclusion, the results of this report promote interest in the discovery of alternative natural compounds with antimicrobial activity against therapy-resistant oral microorganisms. Overall, extracts from O. europaea, mastic gum, and I. viscosa were active against the tested oral pathogens, especially Gram-negative anaerobic bacteria, and could therefore be considered as alternative natural anti-infectious agents which could be used against periodontitis.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

A. Sofrata, E. M. Santangelo, M. Azeem, A. Borg-Karlson, A. Gustafsson, and K. Pütsep, “Benzyl isothiocyanate, a major component from the roots of Salvadora persica is highly active against Gram-Negative bacteria,” PLoS ONE, vol. 6, no. 8, Article ID e23045, 2011.

C. J. Paddon, P. J. Westfall, D. J. Pitera et al., “High-level semi-synthetic production of the potent antimalarial artemisinin,” Nature, vol. 496, no. 7446, pp. 528–532, 2013.

Y. Takebe, C. J. Saucedo, G. Lund et al., “Antiviral lectins from red and blue-green algae show potent in vitro and in vivo activity against hepatitis C virus,” PLoS ONE, vol. 8, no. 5, Article ID e64449, 2013.

D. S. Trentin, D. B. Silva, M. W. Amaral et al., “Tannins possessing bacteriostatic effect impair Pseudomonas aeruginosa adhesion and biofilm formation,” PLoS ONE, vol. 8, no. 6, Article ID e66257, 2013.

C. Spanou, D. Stagos, L. Tousias et al., “Assessment of antioxidant activity of extracts from unique Greek varieties of Leguminosae plants using in vitro assays,” Anticancer Research, vol. 27, no. 5A, pp. 3403–3410, 2007.

S. Paraschos, S. Mitakou, and A.-L. Skaltsounis, “Chios gum mastic: a review of its biological activities,” Current Medicinal Chemistry, vol. 19, no. 14, pp. 2292–2302, 2012.

E. M. Odiatou, A. L. Skaltsounis, and A. I. Constantinou, “Identification of the factors responsible for the in vitro pro-oxidant and cytotoxic activities of the olive polyphenols oleuropein and hydroxytyrosol,” Cancer Letters, vol. 330, no. 1, pp. 113–121, 2013.

N. Silva, S. Alves, A. Goncalves, J. S. Amaral, and P. Poeta, “Antimicrobial activity of essential oils from Mediterranean aromatic plants against several foodborne and spoilage bacteria,” Food Science and Technology International, vol. 19, no. 6, pp. 503–10, 2013.

C. C. Liolios, K. Graikou, E. Skaltsa, and I. Chinou, “Dittany of Crete: a botanical and ethnopharmacological review,” Journal of Ethnopharmacology, vol. 131, no. 2, pp. 229–241, 2010.

E. González-Burgos, M. E. Carretero, and M. P. Gómez-Serranillos, “Sideritis spp.: uses, chemical composition and pharmacological activities—a review,” Journal of Ethnopharmacology, vol. 135, no. 2, pp. 209–225, 2011.

L. T. Ngo, J. I. Okogun, and W. R. Folk, “21st Century natural product research and drug development and traditional medicines,” Natural Product Reports, vol. 30, no. 4, pp. 584–592, 2013.

S. Hemaiswarya, A. K. Kruthiventi, and M. Doble, “Synergism between natural products and antibiotics against infectious diseases,” Phytomedicine, vol. 15, no. 8, pp. 639–652, 2008.

R. Maor and K. Shirasu, “The arms race continues: Battle strategies between plants and fungal pathogens,” Current Opinion in Microbiology, vol. 8, no. 4, pp. 399–404, 2005.

J. L. Dangl and J. D. G. Jones, “Plant pathogens and integrated defence responses to infection,” Nature, vol. 411, no. 6839, pp. 826–833, 2001.

T. J. Battin, W. T. Sloan, S. Kjelleberg et al., “Microbial landscapes: New paths to biofilm research,” Nature Reviews Microbiology, vol. 5, no. 1, pp. 76–81, 2007.

B. J. Keijser, E. Zaura, S. M. Huse et al., “Pyrosequencinq analysis of the oral microflora of healthy adults,” Journal of Dental Research, vol. 87, no. 11, pp. 1016–1020, 2008.

S. S. Socransky and A. D. Haffajee, “Dental biofilms: difficult therapeutic targets,” Periodontology 2000, vol. 28, no. 1, pp. 12–55, 2002.

A. Al-Ahmad, A. Wunder, T. M. Auschill et al., “The in vivo dynamics of Streptococcus spp., Actinomyces naeslundii, Fusobacterium nucleatum and Veillonella spp. in dental plaque biofilm as analysed by five-colour multiplex fluorescence in situ hybridization,” Journal of Medical Microbiology, vol. 56, no. 5, pp. 681–687, 2007.

L. Karygianni, M. Follo, E. Hellwig et al., “Microscope-based imaging platform for large-scale analysis of oral biofilms,” Applied and Environmental Microbiology, vol. 78, no. 24, pp. 8703–8711, 2012.

K. Smith, D. P. Robertson, D. F. Lappin, and G. Ramage, “Commercial mouthwashes are ineffective against oral MRSA biofilms,” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol. 115, no. 5, pp. 624–629, 2013.

A. Al-Ahmad, H. Ameen, K. Pelz et al., “Antibiotic resistance and capacity for biofilm formation of different bacteria isolated from endodontic infections associated with root-filled teeth,” Journal of Endodontics, vol. 40, no. 2, pp. 223–230, 2014.

J. D. Kyriazis, N. Aligiannis, P. Polychronopoulos, A. Skaltsounis, and E. Dotsika, “Leishmanicidal activity assessment of olive tree extracts,” Phytomedicine, vol. 20, no. 3-4, pp. 275–281, 2013.

A. Agalias, P. Magiatis, A. L. Skaltsounis et al., “A new process for the management of olive oil mill waste water and recovery of natural antioxidants,” Journal of Agricultural and Food Chemistry, vol. 55, no. 7, pp. 2671–2676, 2007.

S. Paraschos, P. Magiatis, S. Mitakou et al., “In vitro and in vivo activities of chios mastic gum extracts and constituents against Helicobacter pylori,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 2, pp. 551–559, 2007.

NCCLS, National Committee for Clinical Laboratory Standards, NCCLS, Wayne, Pa, USA, 1999.

NCCLS, National Committee for Clinical Laboratory Standards, NCCLS, Villanova, Pa, USA, 6th edition, 2003.

A. P. Pereira, I. C. F. R. Ferreira, F. Marcelino et al., “Phenolic compounds and antimicrobial activity of olive (Olea europaea L. Cv. Cobrançosa) leaves,” Molecules, vol. 12, no. 5, pp. 1153–1162, 2007.

O.-H. Lee and B.-Y. Lee, “Antioxidant and antimicrobial activities of individual and combined phenolics in Olea europaea leaf extract,” Bioresource Technology, vol. 101, no. 10, pp. 3751–3754, 2010.

E. Zoidou, E. Melliou, E. Gikas, A. Tsarbopoulos, P. Magiatis, and A. Skaltsounis, “Identification of throuba thassos, a traditional Greek table olive variety, as a nutritional rich source of oleuropein,” Journal of Agricultural and Food Chemistry, vol. 58, no. 1, pp. 46–50, 2010.

A. N. Sudjana, C. D'Orazio, V. Ryan et al., “Antimicrobial activity of commercial Olea europaea (olive) leaf extract,” International Journal of Antimicrobial Agents, vol. 33, no. 5, pp. 461–463, 2009.

D. Markín, L. Duek, and I. Berdícevsky, “In vitro antimicrobial activity of olive leaves,” Mycoses, vol. 46, no. 3-4, pp. 132–136, 2003.

J. Pagès and L. Amaral, “Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria,” Biochimica et Biophysica Acta, vol. 1794, no. 5, pp. 826–833, 2009.

L. J. V. Piddock, “Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria,” Clinical Microbiology Reviews, vol. 19, no. 2, pp. 382–402, 2006.

M. Friedman, P. R. Henika, and R. E. Mandrell, “Bactericidal activities of plant essential oils and some of their isolated constituents against Campylobacter jejuni, Escherichia coli, Listeria monocytogenes, and Salmonella enterica,” Journal of Food Protection, vol. 65, no. 10, pp. 1545–1560, 2002.

B. Gray, P. Hall, and H. Gresham, “Targeting agr- and agr-like quorum sensing systems for development of common therapeutics to treat multiple gram-positive bacterial infections,” Sensors, vol. 13, no. 4, pp. 5130–5166, 2013.

J. S. Wright III, K. E. Traber, R. Corrigan, S. A. Benson, J. M. Musser, and R. P. Novick, “The agr radiation: an early event in the evolution of staphylococci,” Journal of Bacteriology, vol. 187, no. 16, pp. 5585–5594, 2005.

H. K. Obied, P. D. Prenzler, S. H. Omar et al., “Pharmacology of olive biophenols,” Advances in Molecular Toxicology, vol. 6, pp. 195–242, 2012.

P. Magiatis, E. Melliou, A. Skaltsounis, I. B. Chinou, and S. Mitaku, “Chemical composition and antimicrobial activity of the essential oils of Pistacia lentiscus var. chia,” Planta Medica, vol. 65, no. 8, pp. 749–752, 1999.

C. Koutsoudaki, M. Krsek, and A. Rodger, “Chemical composition and antibacterial activity of the essential oil and the gum of Pistacia lentiscus Var. chia,” Journal of Agricultural and Food Chemistry, vol. 53, no. 20, pp. 7681–7685, 2005.

H. Sakagami, K. Kishino, M. Kobayashi et al., “Selective antibacterial and apoptosis-modulating activities of mastic,” In Vivo, vol. 23, no. 2, pp. 215–224, 2009.

K. Takahashi, M. Fukazawa, H. Motohira, K. Ochiai, H. Nishikawa, and T. Miyata, “A pilot study on antiplaque effects of mastic chewing gum in the oral cavity,” Journal of Periodontology, vol. 74, no. 4, pp. 501–505, 2003.

M. Maoz and I. Neeman, “Effect of Inula viscosa extract on chitin synthesis in dermatophytes and Candida albicans,” Journal of Ethnopharmacology, vol. 71, no. 3, pp. 479–482, 2000.

A. B. Sassi, F. Harzallah-Skhiri, N. Bourgougnon, and M. Aouni, “Antiviral activity of some Tunisian medicinal plants against Herpes simplex virus type 1,” Natural Product Research, vol. 22, no. 1, pp. 53–65, 2008.

W. H. Talib, M. H. Abu Zarga, and A. M. Mahasneh, “Antiproliferative, antimicrobial and apoptosis inducing effects of compounds isolated from Inula viscosa,” Molecules, vol. 17, no. 3, pp. 3291–3303, 2012.

A. Gökbulut, O. Özhan, B. Satilmis, K. Batçioglu, S. Günal, and E. Şarer, “Antioxidant and antimicrobial activities, and phenolic compounds of selected inula species from Turkey,” Natural Product Communications, vol. 8, no. 4, pp. 475–478, 2013.

W. Wang, B. H. Ben-Daniel, and Y. Cohen, “Control of plant diseases by extracts of Inula viscosa,” Phytopathology, vol. 94, no. 10, pp. 1042–1047, 2004.

J. Y. Chung, J. H. Choo, M. H. Lee, and J. K. Hwang, “Anticariogenic activity of macelignan isolated from Myristica fragrans (nutmeg) against Streptococcus mutans,” Phytomedicine, vol. 13, no. 4, pp. 261–266, 2006.

R. A. Neumegen, A. R. Fernández-Alba, and Y. Chisti, “Toxicities of triclosan, phenol, and copper sulfate in activated sludge,” Environmental Toxicology, vol. 20, no. 2, pp. 160–164, 2005.